CDYO, page-40

I don't believe Cellmid is manipulated.

The companys SP performance is a consequence of having to raise capital in a weak position. The reality is Cellmid listed too early and paid the price. I suspect if Cellmid floated today it would have doule the market with lots of blue sky priced in (growing evolis sales, US launch & MK IP).

I cant help but draw parallels between Cellmid and Somnomed (ticker SOM).

Somnomed have a basic, but patented device that treats obstructive sleep apnea. For years the stock traded sideways between 1 & 3c. Then out of the blue the firm expanded its distribution network hitting the US (sound familiar?) significantly ramping up sales.

Mr market noticed and couldn't ignore the businesses fundamentals. The stock trades at around $4 today (market cap 250 million).

Food for thought. Somnomed traded sideways for 4 years.

Pull up a long term chart for a comparison.